Enviomycin

Known as: Viomycin, 1-((3R,4R)-4-hydroxy-3,6-diaminohexanoic acid)-6-(L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine)-, (R)-, Tuberactinomycin N, Enviomycin [Chemical/Ingredient] 
Cyclic basic peptide related to VIOMYCIN. It is isolated from an induced mutant of Streptomyces griseoverticillatus var. tuberacticus and acts as an… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
A total of 53 Mycobacterium tuberculosis strains were examined to evaluate the consistency of susceptibility tests using two… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
1992
1992
Bacteriostatic and bactericidal activities of rifampicin, isoniazid, streptomycin, enviomycin and ethambutol against… (More)
Is this relevant?
1989
1989
The rate of sputum conversion (continuously negative cultures for six months or more) was compared among four regimens given to… (More)
  • table 1
  • table 2
Is this relevant?
1985
1985
The binding of 14C-labelled tuberactinomycin O was analysed in equilibrium dialysis cells. The ionic conditions and the… (More)
Is this relevant?
1976
1976
Viomycin, a peptide antibiotic, reduced the amounts of dihydrostreptomycin bound to ribosomes of Myobacterium smegmatis and… (More)
Is this relevant?
1975
1975
Phenotypes of isolates of Mycobacterium tuberculosis H37RV showing resistance to the aminoglucoside antibiotics streptomycin… (More)
Is this relevant?